𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Longitudinal changes in serum her-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients

✍ Scribed by M Pichon; A Bethune-Volters; M Labroquère; S Guepratte; K Hacene; R Neumann; W Carney

Book ID
118622235
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
322 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative HER2 protein levels predict
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab
✍ Allan Lipton; Wolfgang J. Köstler; Kim Leitzel; Suhail M. Ali; Jeff Sperinde; Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

## Abstract ## BACKGROUND: Only a portion of breast cancer patients currently selected for trastuzumab therapy respond. ## METHODS: Using a novel assay (HERmark) to quantify total human epidermal growth factor receptor 2 (HER2) expression, the authors examined outcomes in 102 trastuzumab‐treated